Nortem (Temazepam)

Temazepam, the active ingredient in Nortem, is a benzodiazepine presented as an oral dosage form for oral use. It is prescribed for the short‑term management of insomnia in adult patients who have difficulty initiating or maintaining sleep and may improve overall sleep quality under medical supervision.

GNH USA supplies Nortem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with a focus on quality assurance, regulatory compliance and reliable global logistics for all approved markets.

Temazepam is a benzodiazepine that enhances GABA activity to promote sleep in patients with sleep disorders.

- Insomnia (short‑term): facilitates faster sleep onset and reduces nighttime awakenings in adults. - Sleep onset insomnia: helps patients who have difficulty falling asleep within 30 minutes. - Sleep maintenance insomnia: reduces frequency of nocturnal awakenings and improves sleep continuity.

Temazepam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Drowsiness - Dizziness - Fatigue - Impaired coordination - Memory problems - Headache

Serious or Rare Side Effects: - Respiratory depression - Severe allergic reactions (e.g., rash, swelling) - Paradoxical agitation or aggression - Dependence and withdrawal syndrome - Depression or suicidal thoughts - Marked hypotension

When prescribing Temazepam, clinicians should consider several safety measures.

- Assess patient history: evaluate for prior benzodiazepine use or substance abuse. - Avoid use in elderly: increased risk of falls and cognitive impairment. - Monitor for depression: may exacerbate depressive symptoms. - Do not combine with alcohol: risk of profound CNS depression. - Pregnancy and lactation: use only if benefits outweigh risks. - Store at ambient temperature: keep in original container, protect from moisture and light.

Temazepam can interact with other medications, requiring careful management.

Major Interactions (Avoid): - Opioids: additive respiratory depression. - Alcohol: enhanced sedation and risk of overdose. - CNS depressants (e.g., barbiturates, antihistamines): profound CNS depression.

Moderate Interactions (Monitor Closely): - Antidepressants (e.g., SSRIs): may increase sedation. - Anticonvulsants (e.g., carbamazepine): may reduce temazepam levels. - CYP3A4 inhibitors (e.g., ketoconazole): may increase plasma concentration.